Chime Biologics inks over $190m

Chime Biologics, a China-based provider of outsourcing services for biopharmaceutical development and manufacturing, has raised over $190 million in funding.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this